Correction to: Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance - Thatcher Heumann; Nilofer Azad (Cancer and Metastasis Reviews, 2021)

Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance - Thatcher Heumann; Nilofer Azad (Cancer and Metastasis Reviews, 2021)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine - Sarah Derks; Arjen H. G. Cleven; Veerle Melotte; Kim M. Smits; Johann C. Brandes; Nilofer Azad; Wim van Criekinge; Adriaan P. de Bruïne; James G. Herman; Manon van Engeland (Cancer and Metastasis Reviews, 2013)